Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 168, Issue 4, Pages 1385-1395Publisher
AMER SOC INVESTIGATIVE PATHOLOGY, INC
DOI: 10.2353/ajpath.2006.040748
Keywords
-
Categories
Funding
- NHLBI NIH HHS [R01 HL077360, HL-61731, R01 HL035297, HL-57934, HL-77360, HL-35297] Funding Source: Medline
Ask authors/readers for more resources
Macrophage-mediated inflammation is central to atherogenesis. We have determined previously that the CXC chemokine receptor CXCR2 is involved in advanced atherosclerosis. We sought to determine whether one of the ligands of CXCR2, KC/GRO-alpha, can also modulate atherogenesis. KC/GRO-alpha(-/-) mice were generated and mated with the atherosclerosis-prone LDLR-/- mice. There was a significant reduction in atherosclerosis in mice lacking KC/GRO-a; however, this reduction was only approximately half that seen previously in mice lacking CXCR2 in the leukocyte. To determine whether CXCR2 is involved in the early formation of atherosclerosis, leukocyte-specific CXCR2(-/-) chimeric mice on LDLR-/- background were generated. Early fatty streak lesion formation in these mice was not affected by leukocyte CXCR2 deficiency whereas lesions were less developed in mice lacking leukocyte CXCR2 when atherosclerosis was allowed to progress to the intermediate stage. Macrophages; were relatively sparse in the lesions of leukocyte CXCR2-/- mice despite robust MCP-1 expression. These studies indicate that KC/ GRO-alpha/CXCR2 does not play a critical role in recruitment of macrophages into early atherosclerotic lesions but both arterial KC/GRO-a and leukocyte-specific CXCR2 expression are central to macrophage accumulation. in established fatty streak lesions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available